Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study. - Wikidata - wikimedia - TriplyDB

Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

http://www.wikidata.org/entity/Q36693904

about

Advances in the epidemiology of heart failure and left ventricular remodeling What do we currently know about metabolic syndrome and atrial fibrillation?The role of metabolic syndrome in heart failure A comparison of risk factors for mortality from heart failure in Asian and non-Asian populations: an overview of individual participant data from 32 prospective cohorts from the Asia-Pacific Region.The Impact of Lipoproteins on Wound Healing: Topical HDL Therapy Corrects Delayed Wound Healing in Apolipoprotein E Deficient Mice.Relationship between lipids levels and right ventricular volume overload in congestive heart failure.Lipid lowering and HDL raising gene transfer increase endothelial progenitor cells, enhance myocardial vascularity, and improve diastolic function.Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure Selective homocysteine lowering gene transfer improves infarct healing, attenuates remodelling, and enhances diastolic function after myocardial infarction in mice Blood lipids and the incidence of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis and the Framingham Heart Study.Diabetes and the risk of heart failure Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial.High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K/Akt pathway.Patient perception versus medical record entry of health-related conditions among patients with heart failure.Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes Beneficial effects of selective HDL-raising gene transfer on survival, cardiac remodelling and cardiac function after myocardial infarction in mice.Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy.Low cholesterol is associated with mortality from stroke, heart disease, and cancer: the Jichi Medical School Cohort Study Heart Failure in Women--Insights from the Framingham Heart Study.Association of lipids with incident heart failure among adults with and without diabetes mellitus: Multiethnic Study of Atherosclerosis.Recovery of Serum Cholesterol Predicts Survival After Left Ventricular Assist Device Implantation Metabolic syndrome and heart failure--the risk, paradox, and treatment.Cardiac remodeling at the population level--risk factors, screening, and outcomes.Dyslipidaemia in patients with established cardiovascular disease in Sub-Saharan Africa: a systematic review and meta-analysis.Atrial fibrillation and diabetes mellitus. Correlation, co-existence, and coagulation therapy.Cholesterol-Lowering Gene Therapy Counteracts the Development of Non-ischemic Cardiomyopathy in Mice.High-density lipoprotein protects cardiomyocytes from oxidative stress via the PI3K/mTOR signaling pathway.Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure.High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure.The impact of nontraditional lipid profiles on left ventricular geometric abnormalities in general Chinese population.Association Between Blood Lipid Profiles and Atrial Fibrillation: A Case-Control Study.

P2860

Q26827147-3B4B8573-9E6E-4AD3-96E2-14DB06730A83 Q26864437-6A39E465-1B7E-41C0-88D4-762B712E3242 Q28085668-5A893528-4C01-4CA7-B359-50A5DC7EF61B Q30828094-71465E46-EA9B-465F-AB4A-A6222BED4C55 Q33584728-51C141F3-9251-4928-ADD2-BB250695006D Q34260428-CF56AE53-9D19-4EFA-A5EA-E41483C739E7 Q34442291-D0142F60-7100-4D62-97C6-7CD546060A8D Q34504604-C46E5DCE-1BBB-4EA1-AA8E-5C2E5046E320 Q34723001-BF8C94BC-D564-4CE3-A8F9-3ED17030B0C8 Q35070863-5A3C82C3-CBB2-465A-95D2-1C9BAE72DFBF Q35571144-817FBA0F-65C3-4493-AE87-AAD3287B88FF Q35903590-EC947FF4-3920-48C2-B39E-766545FFD845 Q35995098-C1456EF1-A973-4E8B-8C96-AD2026CB342E Q36930361-FB903CDE-9641-4D00-B265-76A82DDF5241 Q37278695-3796FFEC-2F30-467A-BE65-6A669764238A Q37289676-D89F01B7-40CE-49F8-90F9-AD739D63DD75 Q37464185-0880BF5E-A4CB-4C8F-BCC6-EEDA486AE227 Q37506617-C4D57055-9379-4557-8EB1-F04790AD1C06 Q37637447-87D496F8-3F0C-42A1-A114-FC9A877112DE Q37710585-2A8D8D23-ED69-4CCF-B573-72AEEBE2D588 Q37733657-4619F24C-FB11-4C7B-8BFB-BAF691F5CC14 Q37836629-342931A0-E45F-4335-A5D6-DC36CF2EE532 Q37949515-158C1D79-B287-4357-AE5E-08FD3A1ED6EF Q38041078-1C6FD230-A634-4B91-8C1C-22A84F624F1B Q39635843-3F8EEA7C-1C47-4140-91B8-9771887653F8 Q40077690-465D245F-2396-4933-AD27-689CC90DF962 Q41627722-11DB023A-0445-4439-8B8B-DBC11E4F2BD5 Q41660276-6D9F72A8-1F9B-4CAB-959C-14E1A67EA2D3 Q47281852-4D3D2FA4-170A-4DBD-853A-9BB4AD874489 Q47980523-1383774F-55F7-45DD-B664-6B212100C460 Q55340154-FC7890AE-B470-4A1C-B432-402096960007 Q55496245-83CED351-913A-4746-B649-1B9F35EBB4B7

P2860

Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

http://www.wikidata.org/entity/Q36693904

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

@ast

Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

@en

type

label

Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

@ast

Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

@en

prefLabel

Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

@ast

Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

@en

P1433

Q36693904-8E6894C5-40AA-4E77-801A-AF0359C61A9D

P1476

Q36693904-E0679D8F-D8C1-4E7D-B90E-D1A447F2627B

P2093

Q36693904-438132F8-948E-4843-AED8-14D5D0A90958

Q36693904-7478E955-DF9B-469F-AAF1-4D5477308ABD

Q36693904-C0AF6707-693A-4B16-ADF9-E0BCD6FD1F89

P2860

Q36693904-00B1D239-A6DC-4D89-BAB0-1A4BED3C6662

Q36693904-068833C5-A2C5-41BE-989D-0941F95CAD3C

Q36693904-118F537F-7756-46EC-BF55-073FFCCE5608

Q36693904-228BF91E-8651-4930-AD10-87F94E78AFB7

Q36693904-297DD125-8FE2-47EC-8514-047497DE2B49

Q36693904-30471444-5E2B-4C26-9DA9-C2D170BBC016

Q36693904-34F8D812-B69C-4BF0-AA46-86611D08D8A6

Q36693904-363B11B5-B514-4DFB-B347-40769CF3D51A

Q36693904-36A33F6E-6DD4-4B87-9817-1C3CE8D67A77

Q36693904-39DB7098-0A63-4B3F-9DCC-4F822D95B396

P304

Q36693904-E6D249CC-3E85-410C-A22C-0E89A5BB2CE4

P31

Q36693904-C4D58E99-E127-43AD-B54E-7A8A7B02C8BA

P356

Q36693904-D1B4F85E-CD38-4724-A9EE-D1EF335588A6

P407

Q36693904-0C9F75C9-6941-465B-976D-9F86D635E6EA

P433

Q36693904-2DB8FA79-BAB2-4761-A4DF-159B7FDCFDDF

P478

Q36693904-42F44028-8A7C-4BFB-8E16-1DD78A7D6AB2

P50

Q36693904-0C579104-5218-4BFE-A5C4-0473E7CA10EC

Q36693904-38FE232C-BE84-4850-A322-A6D61D239D4C

Q36693904-B6489711-7F01-489D-84B1-82E083B0A3B8

P577

Q36693904-79179B30-0659-4CEA-877F-57340EE6ADB4

P698

Q36693904-A5752465-777B-45F3-BE3E-6AB24AF0E7D4

P921

Q36693904-D78B554A-6892-4CA2-9D18-C8212D0ADC8E

P932

Q36693904-94844B34-6035-4F07-BC5C-5B44D5954489

P356

CIRCULATIONAHA.109.830984

P1433

P1476

Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

@en

P2093

Daniel Levy

http://www.w3.org/2001/XMLSchema#string

Raghava S Velagaleti

http://www.w3.org/2001/XMLSchema#string

William B Kannel

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity.

Changing epidemiological features of cardiac failure.

Unrecognized myocardial infarction.

Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I.

Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells.

The natural history of congestive heart failure: the Framingham study.

Rosuvastatin in older patients with systolic heart failure.

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

P304

2345-2351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.109.830984

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

Ramachandran S. Vasan

Joseph M Massaro

Sander J Robins

P577

2009-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19933936

http://www.w3.org/2001/XMLSchema#string

P921

P932

3600834

http://www.w3.org/2001/XMLSchema#string